Nitroprusside

DB00325ApprovedInvestigationalSmall moleculeDirect VasodilatorsVasodilating Agents

Nitroprusside is a direct acting vasodilator used to treat hypertension, to induce controlled hypotension to reduce postoperative bleeding, and to manage acute heart failure. Nitroprusside serves as a source of nitric oxide, a potent peripheral vasodilator that affects both arterioles and venules (venules more than arterioles).

Chemical structure of Nitroprusside
Mechanism
Curator reviewed
Primary indication
For immediate reduction of blood pressure of patients in hypertensive crises, reduce bleeding during surgery, and for the treatment of acute congestive heart failureCurator reviewed · 3 structured indications
Formula / weight
C5FeN6O · 215.938 g/mol (avg)
First approval
Canada, 2008 · United States, 2005
Also known as
Nitroferricyanide
Brand names
  • Nipride RTU
  • Nitropress

Resolves to

Structure
InChIKeyASPOIVQEUUCDQT-UHFFFAOYSA-NSMILESO=N[Fe--](C#N)(C#N)(C#N)(C#N)C#N

What you can answer from here — as of September 23, 2026

6Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
1,260Drug interactionsStructured to mechanism, not free text
Sign in
62Clinical trialsPhase, status and sponsor resolved per trial
Sign in
3Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
6ContraindicationsEach with its own population and attribute set
Sign in
55Marketed productsAcross 8 countries and 40 labellers
Sign in
1ATC codeIncluding every combination product, plus 23 drug categories
Sign in
9+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Nitroprusside, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account